J Borenstein //
J Borenstein // Fibromialgia. Cómo pensarla, abordarla y tratarla se realizan para la misma no producen una inmunodepresión, como para considerarla grupo de riesgo. Consideraciones clínicas Es importante no subestimar, si los pacientes con FM refieren una exacerbación de sus síntomas durante el COVID, post-COVID o vacunación. Suena lógico pensar que esto pueda suceder, en este grupo de pacientes que se encuentran sensibilizados. Dado que esto, es lo que pude observar, en estos años acompañando a pacientes con FM, la mejor estrategia es acompañarlos, y no negarles nuevamente (como ya están acostumbrados) la existencia de sus síntomas. Bibliografía • 1. Damla Cankurtaran, Nihal Tezel, Buse Ercan, Sadik Yigit. The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study. Advances in Rheumatology (2021) 61:41. • 2. Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Letter to the Editor (Other) doi:10.1093/rheumatology/keaa738. • 3. J. Rivera, I. Castrejón, L Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study. Clinical and Experimental Rheumatology 2021. • 4. Claire Colas, Audrey Jumel 3, Marie-Pierre Vericel 2. Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown. Frontiers in Psychology. July 2021 | Volume 12 | Article 645092. • 5. Salaffi F, Giorgi V. The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clinical and Experimental Rheumatology 2021. • 6. Wu Y, Xu X, Chen Z et al.: Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22. • 7. Vincent A, Mcalister SJ, Singer W et al.: A report of the autonomic symptom profile in patients with fibromyalgia. J Clin Rheumatol 2014; 20: 106-8. • 8. Di Carlo M, Ventura C, Cesaroni P, Carotti M, et al. Sural nerve size in fibromyalgia syndrome: study on variables associated with cross-sec¬tional area. Front Med 2020; 7: 360. • 9. Fibromyalgia in Health Care Worker during COVID-19 Outbreak in Saudi Arabia, Fahidah AlEnzi 1, Sara Alhamal, Maryam Alramadhan. Frontiers in Public Health | www.frontiersin.org 1 September 2021 | Volume 9 | Article 693159. • 10. Arya B. Mohabbat, MD; Nikita Maria L. Mohabbat Fibromyalgia and Chronic Fatigue Syndrome in the Age of CO- VID-19. FIBROMYALGIA IN THE AGE OF COVID-19. Mayo Clin Proc Inn Qual Out. December 2020;4(6):764-766. • 11. El Covid-19 también puede afectar a los pacientes con Fibromialgia y Síndrome de Fatiga Crónica (SFC). Comité Científico SEFIFAC. • 12. Ciaffi J, Meliconi R, Ruscitti P, et al. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol 2020; 4:65. • 13. Francesco Ursini ,1,2 Jacopo Ciaffi,1 Luana Mancarella, et al. Fibromyalgia: ¿a new facet of the post- CO- VID-19 syndrome spectrum? Results from a web-based survey. RMD Open 2021;7: e001735 • 14. Libby P, Luscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020; 41:3038–44. • 15. Rodriguez-Pinto I, Agmon-Levin N, Howard A, et al. Fibromyalgia and cytokines. Immunol Lett 2014; 161:200–3. • 16. Dennis M. Bierle1, Christopher A Aakre1. Central Sensitization Phenotypes in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome. Journal of Primary Care & Community Health. Volume 12: 1–8.) 2021. • 17. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021; 27:601–15. • 18. Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open -2021;4: e210830. • 19. www.ser.es/wp-content/uploads/2021/03/Posicionamiento-SER-vacunas. • 20. Documento de posicionamiento y recomendaciones en relación con la campaña de vacunación de COVID-19 en pacientes con fibromialgia y síndrome de fatiga crónica. 134
